GlassScriptPhysician profile
Matthew Simmons
NPI 1952620429
$1,758.87
in general payments reported to CMS, 2019-2025
17 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $341 · 2021: $334 · 2022: $127 · 2023: $221 · 2024: $144 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $496.25 | 2019-2024 | Euflexxa |
| Nevro Corp. | $309.84 | 2020-2023 | Senza |
| Pacira Therapeutics, INC. | $203.70 | 2019-2020 | |
| Bioventus LLC | $139.72 | 2019-2025 | Xcell |
| Boston Scientific Corporation | $133.53 | 2021 | |
| Horizon Therapeutics Plc | $132.70 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $60.80 | 2025 | |
| Depuy Synthes Sales INC. | $57.38 | 2019-2025 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $40.42 | 2022-2025 | Iovera, Zilretta |
| Organogenesis INC. | $39.50 | 2022 | |
| Medtronic, INC. | $25.07 | 2024 | Accurian |
| Abbott Laboratories | $24.69 | 2024 | Proclaim |
| Solventum Corporation | $23.83 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Avanos Medical | $22.59 | 2023 | Trivisc Sodium Hyaluronate |
| Vericel Corporation | $19.36 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.